Testing a fluid known as cerebrospinal fluid, or CSF, found surrounding the brain and spinal cord, reveals a lot about brain tumors and the immune response to them. Johns Hopkins neurosurgery department director Chetan Bettegowda and test developer says this …

Can a new test of cerebrospinal fluid be used for many diseases of the brain and spinal cord? Elizabeth Tracey reports Read More »

Tumor components and immune response indicators can be found in cerebrospinal fluid, or CSF, when someone has a brain tumor, in a new test developed by Chetan Bettagowda, director of neurosurgery at Johns Hopkins and one of the test’s developers.  …

Cerebrospinal fluid may hold the keys to brain cancer identification and treatment, Elizabeth Tracey reports Read More »

Your immune system has everything to do with how your body responds to cancer, and brain tumors are no exception. A new test aims to assess that along with characterizing the tumor itself. Chetan Bettegowda, director of neurosurgery at Johns …

What does your immune response have to do with brain tumors? Elizabeth Tracey reports Read More »

Your brain and spinal cord are floating in something called cerebrospinal fluid, or CSF, and when brain tumors develop they shed cells and cellular components into this fluid. A new test developed by director of neurosurgery Chetan Bettegowda at Johns …

Cerebrospinal fluid can tell lots about brain tumors, Elizabeth Tracey reports Read More »

When someone is thought to have a brain tumor procedures to make the diagnosis may be risky or invasive, so a new test developed by Chetan Bettegowda, director of the department of neurosurgery at Johns Hopkins and colleagues is a …

Can assessments of brain cancers be done with cerebrospinal fluid? Elizabeth Tracey reports Read More »

AI assisted colonoscopy, where a computer helped interpret images seen during the procedure, resulted in endoscopists being less adept at recognizing precancerous lesions known as polyps, a recent study finds. Kimmel Cancer Center director William Nelson at Johns Hopkins comments. …

When you have screening colonoscopy should you worry about the endoscopist’s skills? Elizabeth Tracey reports Read More »

If you’ve been treated for early breast cancer your overall risk for recurrence is small, a new large, long term study finds. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says these risks can be pinned to …

Small risks of recurrent breast cancer may exist after treatment, Elizabeth Tracey reports Read More »

Women who’ve had early breast cancer and been treated can likely lay their worries about recurrence to rest, a new study concludes. Johns Hopkins Kimmel Cancer Center director William Nelson says that’s the conclusion of this very large, long term …

Most women who’ve had early breast cancer are not at high risk for recurrence, Elizabeth Tracey reports Read More »

People who’ve had colorectal cancer and have a known mutation should likely take aspirin to help prevent disease recurrence, according to a new study. The benefit of aspirin in preventing cancers has been shown before in the skin cancer melanoma, …

Aspirin may be of benefit in a number of cancers, Elizabeth Tracey reports Read More »

People who’ve had colorectal cancer and who have a mutation known as  PI3 kinase benefit from taking asprin to prevent recurrence, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, describes the findings. Nelson:  There were …

What is the benefit of asprin in reducing colorectal cancer recurrence? Elizabeth Tracey reports Read More »